<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0242583" disease_type="Disease or Syndrome" abbrv="">Bare lymphocyte syndrome</z:e> (BLS) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> <z:hpo ids='HP_0004430'>severe-combined immunodeficiency</z:hpo> that can result from mutations in four different transcription factors that regulate the expression of major histocompatibility complex (MHC) class II genes </plain></SENT>
<SENT sid="1" pm="."><plain>We have identified here the defective gene that is responsible for the phenotype of the putative fifth BLS complementation group </plain></SENT>
<SENT sid="2" pm="."><plain>The mutation was found in the regulatory factor that binds X-box 5 (RFX5) and was mapped to one of the arginines in a DNA-binding surface of this protein </plain></SENT>
<SENT sid="3" pm="."><plain>Its <z:mp ids='MP_0002169'>wild-type</z:mp> counterpart restored binding of the RFX complex to DNA, transcription of <z:hpo ids='HP_0000001'>all</z:hpo> MHC class II genes and the appearance of these determinants on the surface of BLS cells </plain></SENT>
</text></document>